Zomedica Pharmaceuticals Corp. announced that Robert Cohen, Interim Chief Executive Officer, has been appointed to the Company's Board of Directors. Also appointed to the Board of Directors is Christopher Wolfenberg of the law firm Fasken Martineau DuMoulin LLP. Mr. Cohen joined Zomedica in June of 2020 following successfully serving as President and Chief Executive Officer at a series of early stage medical device and biotechnology companies. Prior to his 20 years in the CEO position, he was a member of senior management at large multinationals including St. Jude Medical Inc., Sulzermedica, and Pfizer Inc. Mr. Wolfenberg is a leading business lawyer in Calgary, Canada focused on public and private securities transactions in the technology, energy and mining industries.